Boon Chin Tan

Institution
Universiti Malaya

Country
Malaysia

Field
Agricultural Sciences

Tan received the 2024 Distinguished Scientist Award from the Malaysian Society for Molecular Biology and Biotechnology. Tan has made significant contributions to agricultural research, specializing in plant molecular biology and biochemistry.

 

(Photo: Universiti Malaya)

AWARDS
  • 2024 Distinguished Scientist Award

Related articles

Asia’s Big Biomedical Bet Pays Off

From performing outsourced research and manufacturing generics, Asia's biomedical researchers are now among the world's most innovative.

Seeing Flow Cytometry In A Whole New Light

Combining flexibility, ease of use and sensitivity in one affordable platform, Cytek’s Biosciences Inc.’s Northern Lights flow cytometer promises to bring cell analysis within the reach of many.

Asia’s Scientific Trailblazers: Marcelo Ang

One of Singapore’s robotics pioneers, Professor Marcelo Ang Jr’s research promises to take driverless cars and personal robotic assistants outside the realm of imagination and into the mainstream.

Ctrl-Alt-Meat

Alternative meat, otherwise known as ‘alt-meat,’ is having quite a moment in Asia, with strong venture capital interest and increasing public awareness and acceptance.

Tech Doing Good

From cleaning up mountains of untreated sludge to making railway stations fully solar-powered, technology is an ally to those hoping to solve Asia’s environmental problems.

Asia’s Rising Scientists: Liu Zheng

Associate Professor Liu Zheng is pushing the boundaries of atomically thin materials, a boon for the fields of electronics, energy generation and catalysis.

i-Tiles For Teaching Special Needs Students

Scientists in Singapore have developed an interactive education system to help students with special needs learn better.

Sticky Situations A Boon For Polymer Science

Researchers in Japan have found a way to make industrial polymers sticky without the use of glue or other binding substances.

Genetic Landscape Of ‘Cantonese Cancer’ Mapped

A study of over 100 nasopharyngeal cancer patients has uncovered the genetic basis of the disease and identified possible drug targets.